Health, Social, and Economic Characteristics of Patients Enrolled in a COVID-19 Recovery Program

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2022 Nov 30

PMID 36449517

Authors

Suzanne M Simkovich

Naheed Ahmed

Jiling Chou

Asli McCullers

Eric M Wisotzky

Jennifer Semel

Kathryn Pellegrino

Derek DeLia

William S Weintraub

Affiliations

Soon will be listed here.

Abstract

At least one in five people who recovered from acute COVID-19 have persistent clinical symptoms, however little is known about the impact on quality-of-life (QOL), socio-economic characteristics, fatigue, work and productivity. We present a cross-sectional descriptive characterization of the clinical symptoms, QOL, socioeconomic characteristics, fatigue, work and productivity of a cohort of patients enrolled in the MedStar COVID Recovery Program (MSCRP). Our participants include people with mental and physical symptoms following recovery from acute COVID-19 and enrolled in MSCRP, which is designed to provide comprehensive multidisciplinary care and aid in recovery. Participants completed medical questionnaires and the PROMIS-29, Fatigue Severity Scale, Work and Productivity Impairment Questionnaire, and Social Determinants of Health surveys. Participants (n = 267, mean age 47.6 years, 23.2% hospitalized for COVID-19) showed impaired QOL across all domains assessed with greatest impairment in physical functioning (mean 39.1 ± 7.4) and fatigue (mean 60.6 ±. 9.7). Housing or "the basics" were not afforded by 19% and food insecurity was reported in 14% of the cohort. Participants reported elevated fatigue (mean 4.7 ± 1.1) and impairment with activity, work productivity, and on the job effectiveness was reported in 63%, 61%, and 56% of participants, respectively. Patients with persistent mental and physical symptoms following initial illness report impairment in QOL, socioeconomic hardships, increased fatigue and decreased work and productivity. Our cohort highlights that even those who are not hospitalized and recover from less severe COVID-19 can have long-term impairment, therefore designing, implementing, and scaling programs to focus on mitigating impairment and restoring function are greatly needed.

References

Vanichkachorn G, Newcomb R, Cowl C, Murad M, Breeher L, Miller S . Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort. Mayo Clin Proc. 2021; 96(7):1782-1791. PMC: 8112396. DOI: 10.1016/j.mayocp.2021.04.024. View

Krupp L, Larocca N, Steinberg A . The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989; 46(10):1121-3. DOI: 10.1001/archneur.1989.00520460115022. View

Jacobs L, Gourna Paleoudis E, Lesky-Di Bari D, Nyirenda T, Friedman T, Gupta A . Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020; 15(12):e0243882. PMC: 7732078. DOI: 10.1371/journal.pone.0243882. View

Grace J, Mendelsohn A, Friedman J . A comparison of fatigue measures in Parkinson's disease. Parkinsonism Relat Disord. 2006; 13(7):443-5. DOI: 10.1016/j.parkreldis.2006.09.001. View

Menges D, Ballouz T, Anagnostopoulos A, Aschmann H, Domenghino A, Fehr J . Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PLoS One. 2021; 16(7):e0254523. PMC: 8274847. DOI: 10.1371/journal.pone.0254523. View

Carfi A, Bernabei R, Landi F . Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020; 324(6):603-605. PMC: 7349096. DOI: 10.1001/jama.2020.12603. View

Darcis G, Bouquegneau A, Maes N, Thys M, Henket M, Labye F . Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. Int J Infect Dis. 2021; 109:209-216. PMC: 8278829. DOI: 10.1016/j.ijid.2021.07.016. View

Reilly M, Zbrozek A, Dukes E . The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993; 4(5):353-65. DOI: 10.2165/00019053-199304050-00006. View

OSullivan O . Long-term sequelae following previous coronavirus epidemics. Clin Med (Lond). 2020; 21(1):e68-e70. PMC: 7850177. DOI: 10.7861/clinmed.2020-0204. View

10.

Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J . Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020; 81(2):e16-e25. PMC: 7177098. DOI: 10.1016/j.jinf.2020.04.021. View

11.

Batawi S, Tarazan N, Al-Raddadi R, Al Qasim E, Sindi A, Al Johni S . Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS). Health Qual Life Outcomes. 2019; 17(1):101. PMC: 6560892. DOI: 10.1186/s12955-019-1165-2. View

12.

Hays R, Spritzer K, Schalet B, Cella D . PROMIS-29 v2.0 profile physical and mental health summary scores. Qual Life Res. 2018; 27(7):1885-1891. PMC: 5999556. DOI: 10.1007/s11136-018-1842-3. View

13.

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007; 4(10):e296. PMC: 2020495. DOI: 10.1371/journal.pmed.0040296. View

14.

Lau H, Ng G, Jones A, Lee E, Siu E, Hui D . A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome. Aust J Physiother. 2005; 51(4):213-9. PMC: 7130114. DOI: 10.1016/s0004-9514(05)70002-7. View

15.

Straus S, Tosato G, Armstrong G, Lawley T, Preble O, Henle W . Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med. 1985; 102(1):7-16. DOI: 10.7326/0003-4819-102-1-7. View

16.

Valko P, Bassetti C, Bloch K, Held U, Baumann C . Validation of the fatigue severity scale in a Swiss cohort. Sleep. 2008; 31(11):1601-7. PMC: 2579971. DOI: 10.1093/sleep/31.11.1601. View

17.

Groff D, Sun A, Ssentongo A, Ba D, Parsons N, Poudel G . Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw Open. 2021; 4(10):e2128568. PMC: 8515212. DOI: 10.1001/jamanetworkopen.2021.28568. View

18.

Ngai J, Ko F, Ng S, To K, Tong M, Hui D . The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010; 15(3):543-50. PMC: 7192220. DOI: 10.1111/j.1440-1843.2010.01720.x. View

19.

Stefan N, Birkenfeld A, Schulze M . Global pandemics interconnected - obesity, impaired metabolic health and COVID-19. Nat Rev Endocrinol. 2021; 17(3):135-149. DOI: 10.1038/s41574-020-00462-1. View

20.

Higgins V, Sohaei D, Diamandis E, Prassas I . COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2020; 58(5):297-310. DOI: 10.1080/10408363.2020.1860895. View